Assessing the preventive effects of cognitive therapy following relief of depression: A methodological innovation

Journal of Affective Disorders

Volumn 104, Issue 1-3, 2007, Pages 251-261

  Kashner, T Michael ^a,b   Henley, Steven S ^c   Golden, Richard M ^d   Rush, A John ^a   Jarrett, Robin B ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Office of Academic Affiliations   (United States)

^c Martingale Research Corporation   (United States)

^d UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Cognitive therapy; Declining effects model; Discontinuation effects; Recurrent depression; Varying effects model

Indexed keywords

ADULT; ANXIETY; ARTICLE; CALCULATION; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COPING BEHAVIOR; DEPRESSION; EFFECT SIZE; FEMALE; HIGH RISK PATIENT; HUMAN; LEARNING; LONGITUDINAL INTERVAL FOLLOW UP EVALUATION; LONGITUDINAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; SAMPLE SIZE; SINGLE BLIND PROCEDURE; SYMPTOM;

ADOLESCENT; ADULT; AGED; COGNITIVE THERAPY; COHORT STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; RECURRENCE; THERAPIES, INVESTIGATIONAL; TREATMENT OUTCOME;

EID: 35748961675     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2007.04.004     Document Type: Article

References (65)

1. Aalen O.O., Bergan O., Keiding N., and Thormann J. Interaction between life history events: non-parametric analyses of prospective and retrospective data in the presence of censoring. Scand. J. Statist. 7 (1980) 161-171
2. Alexopoulos G.S., Meyers B.S., Young R.C., Kalayam B., Kakuma T., Gabrielle M., Sirey J.A., and Hull J. Executive dysfunction and long-term outcome of geriatric depression. Arch. Gen. Psychiatry 57 (2000) 285-290
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (1994) American Psychiatric Association, Washington, DC
4. American Psychiatric Association. Practice guideline for major depressive disorder in adults. Am. J. Psychiatry 150 suppl 4 (1993) 1-26
5. Amsterdam J., Garcia-Espana F., Fawcett J., Quitkin F., Reimherr F., Rosenbaum J., and Beasley C. Fluoxetine efficacy in menopausal women with and without estrogen replacement. J. Affect. Disord. 35 (1999) 11-17
6. Baldessarini R.J., Tondo L., Faedda G.L., Suppes T.R., Floris G., and Rudas N. Effects of the rate of discontinuing lithium maintenance treatment in bipolar disorders. J. Clin. Psychiatry 57 (1996) 441-448
7. Beeghly M., Weinsberg K.M., Olson K.L., Kernan H., Riley J., and Tronick E.Z. Stability and change in level of maternal depressive symptomatology during the first postpartum year. J. Affect. Disord. 71 (2002) 169-180
8. Bialos D., Giller E., Jatlow P., Docherty J., and Harkness L. Recurrent of depression after discontinuation of long-term amitriptyline treatment. Am. J. Psychiatry 139 (1982) 325-329
9. Blackburn I.M., Eunson K.M., and Bishop S. A two-year naturalistic follow-up of depressed patients treated with cognitive therapy, pharmacotherapy and a combination of both. J. Affect. Disord. 10 (1986) 67-75
10. Claassen C.A., Kashner T.M., Gilfillan S., Larkin G.L., and Rush A.J. Impact of managed care on psychiatric emergency service recidivism. Psychiatr. Serv. 56 (2005) 691-698
11. Cook B.L., Helms P.M., Smith R.E., and Tsai M. Unipolar depression in the elderly: reoccurrence on discontinuation of tricyclic antidepressants. J. Affect. Disord. 10 (1986) 91-94
12. Cox D.R., and Oakes D. Analysis of Survival Data (1984), Chapman and Hall, London, UK
13. Dawson R., Lavori P.W., Coryell W.H., Endicott J., and Keller M.B. Course of treatment received by depressed patients. J. Psychiatr. Res. 33 (1999) 233-242
14. Dennehy E.B., Suppes T., Rush A.J., Miller A.L., Trivedi M.H., Crismon M.L., Carmody T.J., and Kashner T.M. Does provider adherence to a treatment guideline change clinical outcomes for patients with bipolar disorder? Results from the Texas Medication Algorithm Project. Psychol. Med. 35 (2005) 1695-1706
15. Doogan D.P., and Caillard V. Sertraline in the prevention of depression. Br. J. Psychiatry 160 (1992) 217-222
16. Efron B., and Tibshirani R.J. An Introduction to the Bootstrap (1993), Chapman Hall, New York, NY
17. Evans M.D., Hollon S.D., DeRubeis R.J., Piasecki J.M., Grove W.M., Garvey M.J., and Tuason V.B. Differential relapse following cognitive therapy and pharmacotherapy for depression. Arch. Gen. Psychiatry 49 (1992) 802-808
18. Faedda G.L., Tondo L., Baldessarini R.J., Suppes T., and Tohen M. Outcome after rapid vs. gradual discontinuation of lithium treatment in bipolar disorders. Arch. Gen. Psychiatry 50 (1993) 448-455
19. Friedman J.H. Multivariate adaptive regression splines (with discussion). Ann. Stat. 19 (1991) 1
20. Frank E., Kupfer D.J., Perel J.M., Cornes C., Jarrett D.B., Mallinger A.G., Thase M.E., McEachran A.B., and Grochocinski V.J. Three-year outcomes for maintenance therapies in recurrent depression. Arch. Gen. Psychiatry 47 (1990) 1093-1099
21. Frank E., Prien R.F., Jarrett R.B., Keller M.B., Kupfer D.J., Lavori P.W., Rush A.J., and Weissman M.M. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch. Gen. Psychiatry 48 (1991) 851-855
22. Geddes J.R., Carney S.M., Davies C., Furukawa T.A., Kupfer D.J., Frank E., and Goodwin G.M. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 361 (2003) 653-661
23. Georgotas A., McCue R.E., and Cooper T.B. A placebo-controlled comparison of nortriptyline and phenelzine in maintenance therapy of elderly depressed patients. Arch. Gen. Psychiatry 46 (1989) 783-786
24. Golden R.M. Making correct statistical inferences using a wrong probability model. J. Math. Psychol. 38 (1995) 3-20
25. Golden R.M. Mathematical Methods for Neural Network Analysis and Design (1996), MIT Press, Cambridge, MA
26. Greenberg P.E., Leang S.A., and Birnbaum H.G. Cost of depression: current assessment and future directions. Expert Rev. Pharmacoecon. Outcomes Res. 1 (2001) 69-76
27. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 12 (1960) 52-62
28. Harrell Jr. F.E. Regression Modeling Strategies with Application to Linear Models, Logistic Regression, and Survival Analysis (2001), Springer, New York, NY
29. Hastie T., Tivshirani R., and Friedman J. Elements of Statistical Learning: Data Mining, Inference and Prediction (2001), Springer, New York, NY
30. Hochstrasser B., Isaksen P.M., Koponen H., Lauritzen L., Mahnert F.A., Rouillon F., Wade A.G., Andersen M., Pedersen S.F., de Swart J.C.G., and Nil R. Prophylactic effect of citalopram in unipolar recurrent depression. Br. J. Psychiatry 178 (2001) 304-310
31. Hollon S.D., DeRubeis R.J., Shelton R.C., Amsterdam J.D., Salomon R.M., O'Reardon J.P., Lovett M.L., Young P.R., Harman K.L., Freeman B.B., and Gallop R. Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Arch. Gen. Psychiatry 62 (2005) 417-422
32. Hollon S.D., Jarrett R.B., Nierenberg A.A., Thase M.E., Trivedi M., and Rush A.J. Psychotherapy and medication in the treatment of adult and geriatric depression: which monotherapy or combined treatment?. J. Clin. Psychiatry 66 (2005) 455-468
33. Hosmer D.W., and Lemeshow S. Applied Logistic Regression. Second Edition (2000), John Wiley and Sons, New York
34. Jarrett R.B., and Kraft D. Prophylactic cognitive therapy for major depressive disorder. In Session: Psychotherapy in Practice 3 3 (1997) 65-79
35. Jarrett R.B., Kraft D., Doyle J., Foster B.M., Eaves G.G., and Silver P.C. Preventing recurrent depression using cognitive therapy with and without a continuation stage: a randomized clinical trial. Arch. Gen. Psychiatry 58 (2001) 381-388
36. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53 (1958) 457-481
37. Kashner T.M., Carmody T.J., Suppes T., Rush A.J., Crismon M.L., Miller A.L., Toprac M., and Trivedi M. Catching-up on health outcomes: the Texas Medication Algorithm Project. Health Serv. Res. 38 (2003) 311-331
38. Kashner T.M., Rosenheck R., Campinell A.B., Crandall R.G., Garfield N.J., Lapuc P., Pyrcz K., Soyka T., Surís A., and Wicker A. Impact of work therapy on health status among homeless, substance dependent veterans: a randomized controlled trial. Arch. Gen. Psychiatry 59 (2002) 938-944
39. Kashner T.M., Rush A.J., Crismon M.L., Toprac M., Carmody T.J., Miller A.L., Trivedi M., Wicker A., and Suppes T. An empirical analyses of cost outcomes of the Texas Medication Algorithm Project. Psychiatr. Serv. 57 (2006) 648-659
40. Keller M.B., Kocsis J.H., Thase M.E., Gelenberg A.J., Rush A.J., Koran L., Schatzberg A., Russell J., Hirschfeld R., Klein D., McCullough J.P., Fawcett J.A., Kornstein S., LaVange L., and Harrison W. Maintenance phase efficacy of sertraline for chronic depression: a randomized controlled trial. JAMA 280 (1998) 1665-1672
41. Keller M.D., Lavori P.W., Friedman B., Nielsen E., Endicott J., McDonald-Scott P., and Andreasen N. The longitudinal interval follow-up evaluation: a comprehensive method for assessing outcome in prospective longitudinal studies. Arch. Gen. Psychiatry 44 (1987) 540-548
42. Klysner R., Bent-Hansen J., Hansen H.L., Lunde M., Pleidrup E., Poulsen D.L., Andersen M., Erik H., and Petersen H. Efficacy of citalopram in the prevention of recurrent depression in elderly patients: placebo-controlled study of maintenance therapy. Br. J. Psychiatry 181 (2002) 29-35
43. Kocsis J.H., Friedman R.A., Markowitz J.C., Leon A.C., Miller N.L., Gniwcsch L., and Parides M. Maintenance therapy for chronic depression: a controlled clinical trial of desipramine. Arch. Gen. Psychiatry 53 (1996) 769-774
44. Lave J., Frank R., Schulberg H., et al. Cost-effectiveness of treatments for major depression in primary care practice. Arch. Gen. Psychiatry 55 (1998) 645-651
45. Miller A.L., Crismon M.L., Rush A.J., Chiles J., Kashner T.M., Toprac M., Carmody T., Biggs M., Shores-Wilson K., Chiles J., Witte B., Bow-Thomas C., Velligan D.I., Trivedi M., Suppes T., and Shon S. The Texas Medication Algorithm Project (TMAP): clinical results for patients with schizophrenia. Schizophr. Bull. 30 (2005) 627-647
46. Old Age Depression Interest Group. How long should the elderly take anti-depressants? A double-blind placebo-controlled study of continuation/prophylaxis therapy with dothiepin. Br. J. Psychiatry 162 (1993) 175-182
47. Paykel E.S., Scott J., Teasdale J.D., Johnson A.L., Garland A., Moore R., Jenaway A., Cornwall P.L., Hayhurst H., Abbott R., and Pope M. Prevention of relapse in residual depression by cognitive therapy. Arch. Gen. Psychiatry 56 (1999) 829-835
48. Reynolds C.F., Frank E., Houck P.R., Mazumdar S., Dew M.A., Cornes C., Buysse D.J., Begley A., and Kupfer D.J. Which elderly patients with remitted depression remain well with continued interpersonal psychotherapy after discontinuation of antidepressant medication?. Am. J. Psychiatry 154 (1997) 958-962
49. Rothman K.J., and Greenland S. Modern Epidemiology. 2nd ed. (1998), Lippincott, Williams, and Wilkins, Philadelphia, PA
50. Rush A.J., Trivedi M.H., Wisniewski S.R., Stewart J.W., Nierenberg A.A., Thase M.E., Ritz L., Biggs M.M., Warden D., Luther J.F., Shores-Wilson K., Niederehe G., Fava M., and Bupropion S.R. Sertraline, or Venlafaxine-XR after failure of SSRIs for depression. N. Engl. J. Med. 354 12 (2006) 1231-1242
51. Sambamoorthi U., Olfson M., Walkup J.T., and Crystal S. Diffusion of new generation antidepressant treatment among elderly diagnosed with depression. Med. Care 41 (2003) 180-194
52. Savard J., Laberge B., Gauthier J.G., Fournier J.P., Bouchard S., Baril J.G., and Bergeron M.G. Combination of fluoxetine and cognitive therapy for the treatment of major depression among people with HIV infection: a time-series analysis investigation. Cogn. Ther. Res. 22 (1998) 21-46
53. Seber G.A.F., and Wild C.J. Nonlinear Regression (1989), Wiley, New York, NY
54. Shea M.T., Elkin I., Imber S.D., Sotsky S.M., Watkins J.T., Collins J.F., Pilkonis P.A., Beckham E., Glass D.R., Dolan R.T., and Parloff M.B. Course of depressive symptoms over follow-up: findings from the National Institute of Mental Health treatment of depression collaborative research program. Arch. Gen. Psychiatry 49 (1992) 782-787
55. Simon G.E., Von Korff M., Ludman E.J., Katon W.J., Rutter C., Unutzer J., Lin E.H.B., Bush T., and Walker E. Cost-effectiveness of a program to prevent depression relapse in primary care. Med. Care 40 (2002) 941-950
56. Solomon D.A., Miller I.W., Ryan C.E., Keitner G.I., and Kelley J. Recovery from Acute Mood Episodes of Bipolar I Disorder, Presented at the 42nd Annual Meeting of New Clinical Drug Evaluation Unit, Boca Raton, FL, June 10-13, 2002 (2002)
57. Suppes T., Rush A.J., Dennehy E.B., Crismon M.L., Kashner T.M., Toprac M.G., Carmody T.J., Brown S., Biggs M.M., Shores-Wilson K., Witte B., Trivedi M.H., Miller A.L., Altshuler K.Z., and Shon S.P. Texas Medication Algorithm Project, Phase 3 (TMAP): clinical results for patients with a history of mania. J. Clin. Psychiatry 64 4 (2003) 370-382
58. Suppes T., Ozcan M.E., and Carmody T. Response to clozapine of rapid cycling vs. noncycling patients with a history of mania. Bipolar Disord. 6 (2004) 329-332
59. Terra J.L., and Montgomery S.A. Fluvoxamine prevents recurrence of depression: results of a long-term double-blind, placebo-controlled study. Int. Clin. Psychopharmacol. 13 (1998) 55-62
60. Thase M.E., Nierenberg A.A., Keller M.B., and Panagides J. Efficacy of mirtazapine for prevention of depressive relapse: a placebo-controlled double-blind trial of recently remitted high-risk patients. J. Clin. Psychiatry 62 (2001) 782-788
61. Trivedi M.H., Rush A.J., Crismon M.L., Kashner T.M., Toprac M.G., Carmody T.J., Key T., Biggs M.M., Shores-Wilson K., Witte B., Suppes T., Miller A.L., Altshuler K.Z., and Shon S.P. The Texas Medication Algorithm Project (TMAP): clinical results for patients with major depressive disorder. Arch. Gen. Psychiatry 61 (2004) 669-680
62. Versiani M., Mehilae L., Gaszner P., and Arnaud-Castiglioni R. Reboxetine, a unique selective NRI, prevents relapse and recurrence in long-term treatment of major depressive disorder. J. Clin. Psychiatry 60 (1999) 400-406
63. Vos T., Haby M.M., Barendregt J.J., Kruijshaar M., Corry J., and Andrews G. The burden of major depression avoidable by longer-term treatment strategies. Arch. Gen. Psychiatry 61 (2004) 1097-1103
64. White H. Maximum likelihood estimation of misspecified models. Econometrica 50 (1982) 1-25
65. White H. Estimation, Inference, and Misspecification Analysis (1984), Cambridge University Press, New York, NY